Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.
After finishing at $19.24 in the prior trading day, Caredx Inc (NASDAQ: CDNA) closed at $18.45, down -4.11%. In other words, the price has decreased by -$4.11 from its previous closing price. On the day, 0.65 million shares were traded. CDNA stock price reached its highest trading level at $19.01 during the session, while it also had its lowest trading level at $18.37.
Ratios:
Our goal is to gain a better understanding of CDNA by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 4.45 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 50.98. For the most recent quarter (mrq), Quick Ratio is recorded 3.84 and its Current Ratio is at 4.11. In the meantime, Its Debt-to-Equity ratio is 0.08 whereas as Long-Term Debt/Eq ratio is at 0.06.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Wells Fargo on January 15, 2025, Upgraded its rating to Equal Weight and sets its target price to $24 from $28 previously.
On August 28, 2024, Wells Fargo started tracking the stock assigning a Underweight rating and target price of $28.
BTIG Research Upgraded its Neutral to Buy on August 19, 2024, while the target price for the stock was maintained at $40.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jun 18 ’25 when Valantine Hannah sold 10,570 shares for $19.16 per share. The transaction valued at 202,566 led to the insider holds 38,994 shares of the business.
Maag Peter sold 10,000 shares of CDNA for $192,420 on Jun 17 ’25. The Director now owns 318,846 shares after completing the transaction at $19.24 per share. On Jun 18 ’25, another insider, HANNAH VALANTINE, who serves as the Director of the company, bought 10,570 shares for $19.52 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CDNA now has a Market Capitalization of 1027305280 and an Enterprise Value of 887357952. As of this moment, Caredx’s Price-to-Earnings (P/E) ratio for their current fiscal year is 16.01, and their Forward P/E ratio for the next fiscal year is 111.82. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.97 while its Price-to-Book (P/B) ratio in mrq is 2.70. Its current Enterprise Value per Revenue stands at 2.562 whereas that against EBITDA is -35.175.
Stock Price History:
The Beta on a monthly basis for CDNA is 2.25, which has changed by 0.26196992 over the last 52 weeks, in comparison to a change of 0.11708844 over the same period for the S&P500. Over the past 52 weeks, CDNA has reached a high of $34.84, while it has fallen to a 52-week low of $14.09. The 50-Day Moving Average of the stock is 3.71%, while the 200-Day Moving Average is calculated to be -14.61%.
Shares Statistics:
The stock has traded on average 1.10M shares per day over the past 3-months and 841930 shares per day over the last 10 days, according to various share statistics. A total of 55.46M shares are outstanding, with a floating share count of 51.92M. Insiders hold about 6.75% of the company’s shares, while institutions hold 98.45% stake in the company. Shares short for CDNA as of 1749772800 were 6276371 with a Short Ratio of 5.69, compared to 1747267200 on 6558234. Therefore, it implies a Short% of Shares Outstanding of 6276371 and a Short% of Float of 11.53.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
